Company / Free Cash Flow per Share
OCULAR THERAPEUTIX, INC Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.37
FY2025
5-year range
-$1.37 / -$0.71
FY2021-FY2025
Trend
-16.3%
vs FY2024
Sector context
#117 of 192
Health Care
What the data says
At $-1.37, OCULAR THERAPEUTIX, INC's free cash flow per share ranks #117 of 192 in the Health Care sector. Free Cash Flow per Share has declined for 3 consecutive years, from $-0.71 in FY2022 to $-1.37 in FY2025.
Based on SEC 10-K filings.
-1.37 in FY2025.
Declined from $-0.99 to $-1.37 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#117 of 192 in Health CareTop 61% of 192This company -$1.37 Sector average $3.32
▼
-141.4% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's free cash flow per share has declined for 3 consecutive years.
- In FY2025, free cash flow per share decreased 16.3% year-over-year.
- Ranks #117 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.37 | -16.3% |
| FY2024 | -$1.18 | -19.6% |
| FY2023 | -$0.99 | -39.5% |
| FY2022 | -$0.71 | +32.5% |
| FY2021 | -$1.05 | +33.8% |
| FY2020 | -$1.59 | -12.1% |
| FY2019 | -$1.41 | +17.9% |
| FY2018 | -$1.72 | +26.6% |
| FY2017 | -$2.35 | -61.7% |
| FY2016 | -$1.45 | -137.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026